“…They should be prevented, and if occurred; should be diagnosed and managed early to improve graft and patient outcomes, however, those outcomes are affected also by additional variables (i.e. Large for size graft (LFSG), pediatric end-stage liver disease (PELD)/model for end-stage liver disease (MELD) scores, centre experience/volume, operative time, operative blood loss, blood transfusion units, etc); those variables should be modulated also for getting better short-and long-term outcomes [ 8 , [22] , [23] , [24] , [25] , [26] ] .…”